CNS DRUGS is a leading journal dedicated to the field of neuroscience, specifically focused on the advancement of pharmacological therapies for central nervous system disorders. Published by ADIS INT LTD, this esteemed journal has maintained a strong impact within its domain, achieving Q1 rankings in 2023 across multiple categories, including Neurology (clinical), Pharmacology (medical), and Psychiatry and Mental Health. With an impressive Scopus ranking as the 11th of 272 in medical pharmacology and high percentiles in psychiatry and neurology, it fosters high-quality research publication and dissemination. Spanning over two decades from 1994 to 2024, CNS DRUGS serves as a vital resource for researchers, professionals, and students alike, providing comprehensive insights that drive innovation in clinical practices. Although primarily a subscription-based journal, the richness of its content makes it an essential addition to any institution's library. Striving to bridge the gap between scientific research and clinical application, CNS DRUGS is positioned at the forefront of neurological and psychiatric pharmacotherapy research.

ACTA PSYCHIATRICA SCANDINAVICA is a leading journal in the field of Psychiatry and Mental Health, published by Wiley since its inception in 1926. With a strong commitment to advancing psychiatric research, this esteemed journal boasts an impressive impact factor and ranks within the top 7% of its category, reflecting its influence and relevance in the field. Operating without an Open Access model, the journal serves as a vital resource for professionals, researchers, and students keen on accessing high-quality, peer-reviewed studies focused on mental health issues. The scope of ACTA PSYCHIATRICA SCANDINAVICA spans a broad spectrum of psychiatric topics, providing a platform for groundbreaking research and clinical practice insights. Based in the United Kingdom and featuring contributions from experts worldwide, the journal continues to shape the future of psychiatric research through its rigorous publication standards and commitment to scholarly excellence.

Therapeutic Advances in Psychopharmacology is a leading open-access journal published by SAGE Publications Ltd, focusing on the dynamic integration of pharmacological therapies and psychological health. Since its inception in 2011, this journal has made a significant impact on the fields of pharmacology and psychiatry, consistently earning a Q1 ranking in both categories as of 2023, reflecting its esteemed position within the scientific community. With an impressive Scopus rank placing it in the top 15% across relevant disciplines, the journal serves as a vital platform for researchers, professionals, and students eager to explore cutting-edge advancements in psychopharmacology. The open-access model, established in 2019, ensures that groundbreaking research is accessible to a wide audience, fostering collaboration and innovation in therapeutic strategies for mental health disorders. Through the dissemination of high-quality research and reviews, Therapeutic Advances in Psychopharmacology is committed to advancing understanding and practice within this critical field.

Research on Child and Adolescent Psychopathology, with ISSN 2730-7166 and E-ISSN 2730-7174, is a premier academic journal published by Springer, dedicated to advancing the understanding of psychological issues affecting children and adolescents. With an impressive Q1 ranking in both Developmental and Educational Psychology and Psychiatry and Mental Health in 2023, this journal serves as a crucial platform for researchers, practitioners, and students alike, focusing on evidence-based studies, innovative interventions, and the latest trends in child and adolescent mental health. As an Open Access journal, it ensures broader dissemination of knowledge, fostering collaboration and awareness among professionals across disciplines. Rooted in its commitment to tackling critical developmental challenges, Research on Child and Adolescent Psychopathology is not just a publication; it is a vital resource for those dedicated to improving mental health outcomes for young populations in the United States and beyond. Join the conversation as we explore new frontiers in understanding and addressing psychopathological issues.

Child and Adolescent Psychiatry and Mental Health, published by BMC, is a premier open access journal dedicated to advancing the field of mental health and psychiatric care for children and adolescents. Since its inception in 2007, the journal has fostered a global dialogue among researchers, clinicians, and policy makers by disseminating high-quality research that addresses critical issues in child and adolescent psychiatry. With an impressive Q1 ranking in Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health, it holds a significant position within the academic community, ranking 28th out of 330 in its field. This standing enhances its visibility and relevance, appealing to a wide range of professionals interested in evidence-based practices. As an open access journal, it ensures that research is freely accessible to those who need it most, facilitating greater collaboration and progress. The journal is committed to publishing diverse articles that span various aspects of mental health, including preventive measures, therapeutic interventions, and the intersection of mental health with social determinants. Researchers, practitioners, and students alike will find valuable insights and innovations within its pages, making it an indispensable resource in the field.

World Psychiatry is a leading peer-reviewed journal dedicated to advancing the field of psychiatry and mental health. Published by WILEY and located in the United States, this esteemed journal boasts an impressive impact factor, ranking Q1 in the Psychiatry and Mental Health category for 2023. Recognized for its scholarly contributions, World Psychiatry ranks #1 out of 567 in the Scopus database for medicine in psychiatry and mental health, placing it in the top 1% of its field. The journal covers a wide scope of research topics, aiming to facilitate dialogue and innovation among researchers, professionals, and students alike. Though it does not offer open access, its comprehensive articles and analyses are accessible to a broad audience engaged in mental health studies. With converged years from 2007 to 2024, the journal continues to serve as a critical resource for the latest advancements and evidence-based practices in psychiatry.

Journal of Child Science, published by GEORG THIEME VERLAG KG, is a pioneering academic journal dedicated to advancing knowledge in the fields of pediatrics, perinatology, and child health, with a special focus on surgical interventions involving children. Since its inception in 2017, this journal has endeavored to provide a platform for high-quality, peer-reviewed research that addresses critical topics related to child development and health care. With an ISSN of 2474-5871, it occupies a Q4 quartile ranking in both Pediatrics and Surgery as of 2023, demonstrating its growing presence in the academic community. Although currently non-open access, the journal aims to become a vital resource for healthcare professionals, researchers, and students interested in improving child health outcomes through informed and evidence-based practices. With a commitment to upholding rigor and integrity in research, Journal of Child Science stands as an essential avenue for discourse and discovery in child science and medicine.

Journal of the Canadian Academy of Child and Adolescent Psychiatry, published by the esteemed Canadian Academy of Child & Adolescent Psychiatry, serves as a crucial platform for scholarly discourse in the fields of Pediatrics and Psychiatry. With an ISSN of 1719-8429, this journal has been significantly contributing to the advancement of knowledge from 2006 to 2024, achieving notable recognition as a Q2 journal in both Pediatrics, Perinatology and Child Health, and Psychiatry and Mental Health categories. The journal's current Scopus rankings reflect its quality, sitting at the 70th percentile in Pediatrics and the 55th percentile in Psychiatry. Though currently not an open access journal, it provides valuable insights, research findings, and clinical implications for researchers, clinicians, and students dedicated to child and adolescent mental health. Its location in Canada underscores a commitment to advancing healthcare and mental wellness for young populations through rigorous academic inquiry.

The Journal of the Korean Academy of Child and Adolescent Psychiatry (ISSN: 1225-729X; E-ISSN: 2233-9183) stands as a pivotal resource in the fields of child and adolescent mental health, contributing significantly to the dialogue on psychiatric practices and research in South Korea and beyond. Published by the KOREAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY, this journal is recognized for its dedication to advancing the understanding of psychiatric disorders that affect children and adolescents, as evidenced by its Q3 ranking in both Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health categories for 2023. Operated from Seoul, South Korea, the journal facilitates knowledge-sharing among researchers and practitioners, providing insights into clinical practices and innovative treatment methodologies. Although not openly accessible, the journal emphasizes quality over quantity in its selection of studies, making each article a valuable contribution to the field. As the journal continues to publish impactful research through 2024, it remains essential reading for those committed to the well-being of younger populations and their families.

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.